SLC6A3 and Lewy body dementia: Currently EEG can have added value, especially in the more complex cases when there is a clinical suspicion of DLB, such as the DLB/AD+ cases, where (CSF) AD biomarkers are not helpful and/or DLB-patients with an initially negative DAT SPECT (van der Zande et al., 2016).